Abstract
Introduction: Coronary computed tomography angiography (CCTA) with CCTA-derived fractional flow reserve (FFRct) real-world clinical impact has recently been described across multiple International tertiary centers but has not previously been described in the District General hospital setting in the National Health Service (NHS). Furthermore, the impact of FFRct-guided management of time to next investigation / definitive treatment has not been assessed either. We aim to re-address these issues in a prospective single-center observational study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
